Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033131142> ?p ?o ?g. }
- W2033131142 endingPage "408" @default.
- W2033131142 startingPage "404" @default.
- W2033131142 abstract "The incidence of non-AIDS-defining cancer is remarkably higher in HIV-infected than in the general population. In contrast, breast cancer risk is significantly reduced in the HIV-infected population. The molecular mechanisms underlying the phenomenon of suppression of breast cancer in the HIV-infected population may serve as a basis for development of a new platform for prevention and treatment of breast cancer. Various evidences indicate that vasoactive intestinal peptide (VIP) plays an important role in growth, and differentiation of breast cancer. We previously showed (i) that natural antibodies recognizing VIP and the gp120-derived peptide NTM significantly contribute to the control of HIV disease progression by suppression of VIP-like activity of HIV-1 gp120 and (ii) that physical exercise stimulates production of these natural antibodies. These findings suggest that natural anti-VIP/NTM antibodies could contribute to a decrease of breast cancer in the HIV-infected population by suppression of VIP, which may play a pro/oncogenic function. Aerobic exercise which stimulates production of anti-VIP/NTM antibodies could be used as prevention and supportive treatment of breast cancer. Immunotherapy based on natural anti-VIP/NTM antibodies could serve as an effective adjunct therapy for the treatment of breast cancer. Similarly, aerobic exercise, which stimulates production of these antibodies, should be considered as an inexpensive and safe preventive and supportive breast cancer therapy. Natural anti-VIP/NTM antibodies also represent promising prognostic marker for breast cancer." @default.
- W2033131142 created "2016-06-24" @default.
- W2033131142 creator A5008340388 @default.
- W2033131142 creator A5013666961 @default.
- W2033131142 creator A5034001471 @default.
- W2033131142 creator A5040888166 @default.
- W2033131142 creator A5056664099 @default.
- W2033131142 creator A5069185487 @default.
- W2033131142 creator A5069876178 @default.
- W2033131142 date "2011-09-01" @default.
- W2033131142 modified "2023-10-18" @default.
- W2033131142 title "Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer?" @default.
- W2033131142 cites W1496528573 @default.
- W2033131142 cites W150683283 @default.
- W2033131142 cites W1564158644 @default.
- W2033131142 cites W1592354001 @default.
- W2033131142 cites W1599507531 @default.
- W2033131142 cites W159969969 @default.
- W2033131142 cites W1913042601 @default.
- W2033131142 cites W1968276891 @default.
- W2033131142 cites W1970231461 @default.
- W2033131142 cites W1972711035 @default.
- W2033131142 cites W1974198898 @default.
- W2033131142 cites W1975201674 @default.
- W2033131142 cites W1976140679 @default.
- W2033131142 cites W1978900962 @default.
- W2033131142 cites W1981924955 @default.
- W2033131142 cites W1988817783 @default.
- W2033131142 cites W1990657415 @default.
- W2033131142 cites W1992141113 @default.
- W2033131142 cites W1994141569 @default.
- W2033131142 cites W1996319063 @default.
- W2033131142 cites W1999914992 @default.
- W2033131142 cites W2003425309 @default.
- W2033131142 cites W2009164207 @default.
- W2033131142 cites W2009181728 @default.
- W2033131142 cites W2030431254 @default.
- W2033131142 cites W2031543125 @default.
- W2033131142 cites W2032583643 @default.
- W2033131142 cites W2035989122 @default.
- W2033131142 cites W2036587772 @default.
- W2033131142 cites W2038867244 @default.
- W2033131142 cites W2039575830 @default.
- W2033131142 cites W2040614974 @default.
- W2033131142 cites W2042002437 @default.
- W2033131142 cites W2043335225 @default.
- W2033131142 cites W2047431110 @default.
- W2033131142 cites W2048065381 @default.
- W2033131142 cites W2048914368 @default.
- W2033131142 cites W2055951427 @default.
- W2033131142 cites W2062220156 @default.
- W2033131142 cites W2063357723 @default.
- W2033131142 cites W2068067834 @default.
- W2033131142 cites W2072684075 @default.
- W2033131142 cites W2073454150 @default.
- W2033131142 cites W2077384735 @default.
- W2033131142 cites W2080579375 @default.
- W2033131142 cites W2080591412 @default.
- W2033131142 cites W2080900368 @default.
- W2033131142 cites W2081703950 @default.
- W2033131142 cites W2081805554 @default.
- W2033131142 cites W2082445382 @default.
- W2033131142 cites W2085343855 @default.
- W2033131142 cites W2085676179 @default.
- W2033131142 cites W2086871779 @default.
- W2033131142 cites W2090323004 @default.
- W2033131142 cites W2095081508 @default.
- W2033131142 cites W2099232673 @default.
- W2033131142 cites W2113030185 @default.
- W2033131142 cites W2113362147 @default.
- W2033131142 cites W2113444783 @default.
- W2033131142 cites W2114185671 @default.
- W2033131142 cites W2117495256 @default.
- W2033131142 cites W2131550376 @default.
- W2033131142 cites W2133123802 @default.
- W2033131142 cites W2133985933 @default.
- W2033131142 cites W2140685830 @default.
- W2033131142 cites W2141654978 @default.
- W2033131142 cites W2144979694 @default.
- W2033131142 cites W2145334663 @default.
- W2033131142 cites W2150968960 @default.
- W2033131142 cites W2152118650 @default.
- W2033131142 cites W2156323704 @default.
- W2033131142 cites W2166240517 @default.
- W2033131142 cites W2171233661 @default.
- W2033131142 cites W2408786387 @default.
- W2033131142 cites W28456490 @default.
- W2033131142 cites W4210315623 @default.
- W2033131142 doi "https://doi.org/10.1016/j.mehy.2011.05.030" @default.
- W2033131142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21684085" @default.
- W2033131142 hasPublicationYear "2011" @default.
- W2033131142 type Work @default.
- W2033131142 sameAs 2033131142 @default.
- W2033131142 citedByCount "4" @default.
- W2033131142 countsByYear W20331311422014 @default.
- W2033131142 countsByYear W20331311422016 @default.
- W2033131142 countsByYear W20331311422019 @default.
- W2033131142 countsByYear W20331311422021 @default.